Mindera Health Announces Commercial Relocation
27 nov. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, a leading provider of precision medicine solutions for psoriasis, today announced that it will be relocating its commercial...
Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™
06 nov. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on...
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
23 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract...
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
16 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent...
Mindera Health™ Announces Contract With General Services Administration®
10 oct. 2023 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announced that the General Services Administration (GSA) has granted a 5 year contract award to Mindera Health enabling access...
Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
03 oct. 2023 10h00 HE
|
Mindera Health
San Diego, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider...
Mindera Health™ Announces Change to Executive Leadership Team
11 mai 2023 15h57 HE
|
Mindera Health
San Diego, CA, May 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive...
Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending
11 avr. 2023 09h00 HE
|
Mindera Health
San Diego, CA, April 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, has initiated a coverage with evidence project...
Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer
14 mars 2023 08h00 HE
|
Mindera Health
San Diego, CA, March 14, 2023 (GLOBE NEWSWIRE) -- Mindera Health, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has appointed Mr. Linh H. Le as Chief Financial...
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients
20 oct. 2022 08h00 HE
|
Mindera Health
San Diego, CA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at...